ARTICLE | Clinical News
Savvy glyminox: Began Phase I testing
May 3, 1999 7:00 AM UTC
Biosyn Inc., Philadelphia, Penn. Product: Savvy glyminox Therapeutic category: Viral infection Target: Cell membranes of pathogens Description: Vaginal gel formulation of the antimicrobial agent glymi...